Phenytoin-induced encephalopathy in a child

Area of Science:

• Pediatric Neurology
• Clinical Pharmacology
• Toxicology

Background:

• Phenytoin is a widely prescribed antiepileptic drug for pediatric seizure disorders.
• It possesses a narrow therapeutic index, necessitating careful dosing and monitoring.
• Adverse effects are common, but severe complications like encephalopathy are less frequent.

Observation:

• A rare case of phenytoin-induced encephalopathy in a child is presented.
• The overdose resulted from injectable phenytoin administration, stemming from a lack of awareness regarding prior treatments.
• This highlights a critical gap in medication management protocols.

Findings:

• Overdosing with injectable phenytoin can lead to severe neurological toxicity, including encephalopathy, in pediatric patients.
• Inadequate review of a patient's medical history and previous medications significantly increases the risk of accidental overdose.
• Prompt recognition and management of phenytoin toxicity are essential to mitigate neurological damage.

Implications:

• Emphasizes the critical need for thorough medical record scrutiny before administering medications with narrow therapeutic ranges, particularly in pediatric care.
• Highlights the importance of clear communication and documentation of patient treatment history across healthcare providers to prevent medication errors.
• Underscores the potential for severe adverse events, such as encephalopathy, from phenytoin overdose and the necessity of vigilant patient monitoring.